Well-known fund managers are concentrating on entering the market, and public participation in private placement is heating up again.

Recently, the topic of private placement has been heating up in the market, with many heavyweight fund managers focusing on the private placement of Baly Tianheng, attracting high market attention. On September 23, China Europe Fund announced that its China Europe Healthcare and China Europe Medical Innovation funds, managed by Gelan, participated in the private placement of Baly Tianheng's stock. This is Gelan's latest appearance in a private placement project, once again focusing market attention on healthcare-themed funds. Overall, the private placement of Baly Tianheng not only became a stage for healthcare funds to shine, but also reflected that after the volatility in the healthcare sector, public funds are still actively seizing structural opportunities. Whether it is a thematic fund focusing on healthcare in the long term or a comprehensive growth strategy product, they have shown enthusiasm for allocation in this private placement, leaving more room for imagination for future market performance.